XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   20,736,612    
Beginning balance at Dec. 31, 2023 $ 12,656 $ 21 $ 737,810 $ (725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   517,688    
Issuance of common stock 1,160   1,160  
Voluntary surrender of shares by shareholder 0   0  
Stock-based compensation costs 679   679  
Vesting of restricted stock units (in shares)   2,595    
Net loss (20,749)     (20,749)
Ending balance (in shares) at Mar. 31, 2024   21,256,895    
Ending balance at Mar. 31, 2024 (6,254) $ 21 739,649 (745,924)
Beginning balance (in shares) at Dec. 31, 2024   24,875,587    
Beginning balance at Dec. 31, 2024 (33,415) $ 21 752,630 (786,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   108,072    
Issuance of common stock $ 139 $ 0 139  
Voluntary surrender of shares by shareholder (in shares) (301)      
Stock-based compensation costs $ 529   529  
Net loss (11,759)     (11,759)
Ending balance (in shares) at Mar. 31, 2025   24,983,358    
Ending balance at Mar. 31, 2025 $ (44,506) $ 21 $ 753,298 $ (797,825)